Hua‐Long Zheng
Papers
11
Total Citations
458
H-Index
10
About
Hua-Long Zheng is a leading surgical oncologist whose research centers on advancing minimally invasive gastrectomy techniques for gastric cancer, with a particular focus on robotic versus laparoscopic approaches. His landmark 2020 randomized controlled trial comparing robotic and laparoscopic distal gastrectomy (236 citations) established critical evidence on short-term outcomes, while his 2024 phase 2 trial (42 citations) further explored survival differences between these modalities. Zheng's work extends to evaluating technical performance, cost-effectiveness, and surgical burden, notably through prospective economic analyses and propensity score-matched studies. He has pioneered specialized techniques such as Huang's three-step maneuver for spleen-preserving splenic hilar lymphadenectomy, demonstrating robotic advantages in complex procedures. His research also addresses specific patient populations, including elderly individuals and overweight patients, showing robotic gastrectomy as a reliable option with better short-term outcomes. With over 450 total citations across his most-cited works, Zheng has systematically built evidence supporting robotic gastrectomy's safety, efficacy, and economic viability, making him a pivotal figure in defining the role of robotic surgery in gastric cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer236 citations · 2020
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10